Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

EPA:CARM - Euronext Paris - Matif - FR0010828137 - REIT - Currency: EUR

17.2  -0.14 (-0.81%)

Fundamental Rating

6

CARM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. While CARM has a great profitability rating, there are some minor concerns on its financial health. CARM may be a bit undervalued, certainly considering the very reasonable score on growth This makes CARM very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CARM was profitable.
In the past year CARM had a positive cash flow from operations.
CARM had positive earnings in 4 of the past 5 years.
CARM had a positive operating cash flow in each of the past 5 years.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

With a decent Return On Assets value of 4.65%, CARM is doing good in the industry, outperforming 78.05% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.19%, CARM belongs to the top of the industry, outperforming 80.49% of the companies in the same industry.
With a decent Return On Invested Capital value of 4.52%, CARM is doing good in the industry, outperforming 68.29% of the companies in the same industry.
CARM had an Average Return On Invested Capital over the past 3 years of 3.52%. This is in line with the industry average of 4.05%.
The 3 year average ROIC (3.52%) for CARM is below the current ROIC(4.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROIC 4.52%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

The Profit Margin of CARM (61.91%) is better than 75.61% of its industry peers.
CARM's Profit Margin has improved in the last couple of years.
CARM has a Operating Margin of 89.71%. This is amongst the best in the industry. CARM outperforms 87.80% of its industry peers.
In the last couple of years the Operating Margin of CARM has grown nicely.
Looking at the Gross Margin, with a value of 73.12%, CARM is in line with its industry, outperforming 48.78% of the companies in the same industry.
CARM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

5

2. Health

2.1 Basic Checks

CARM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CARM has been reduced compared to 1 year ago.
CARM has more shares outstanding than it did 5 years ago.
CARM has a better debt/assets ratio than last year.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CARM has an Altman-Z score of 0.97. This is a bad value and indicates that CARM is not financially healthy and even has some risk of bankruptcy.
CARM has a Altman-Z score of 0.97. This is comparable to the rest of the industry: CARM outperforms 58.54% of its industry peers.
The Debt to FCF ratio of CARM is 9.40, which is on the high side as it means it would take CARM, 9.40 years of fcf income to pay off all of its debts.
CARM's Debt to FCF ratio of 9.40 is amongst the best of the industry. CARM outperforms 82.93% of its industry peers.
A Debt/Equity ratio of 0.78 indicates that CARM is somewhat dependend on debt financing.
The Debt to Equity ratio of CARM (0.78) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Altman-Z 0.97
ROIC/WACC0.89
WACC5.09%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CARM has a Current Ratio of 1.22. This is a normal value and indicates that CARM is financially healthy and should not expect problems in meeting its short term obligations.
CARM has a better Current ratio (1.22) than 78.05% of its industry peers.
CARM has a Quick Ratio of 1.22. This is a normal value and indicates that CARM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CARM (1.22) is better than 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 15358.74% over the past year.
The Earnings Per Share has been growing by 22.86% on average over the past years. This is a very strong growth
Looking at the last year, CARM shows a quite strong growth in Revenue. The Revenue has grown by 9.72% in the last year.
CARM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.93% yearly.
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%

3.2 Future

Based on estimates for the next years, CARM will show a small growth in Earnings Per Share. The EPS will grow by 4.49% on average per year.
The Revenue is expected to grow by 3.14% on average over the next years.
EPS Next Y6.37%
EPS Next 2Y5.14%
EPS Next 3Y4.49%
EPS Next 5YN/A
Revenue Next Year11.76%
Revenue Next 2Y4.63%
Revenue Next 3Y3.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.78, the valuation of CARM can be described as very cheap.
Based on the Price/Earnings ratio, CARM is valued cheaper than 82.93% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.63. CARM is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 9.60 indicates a reasonable valuation of CARM.
CARM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CARM is cheaper than 70.73% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.72, CARM is valued rather cheaply.
Industry RankSector Rank
PE 7.78
Fwd PE 9.6
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CARM indicates a rather cheap valuation: CARM is cheaper than 82.93% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CARM is valued cheaper than 80.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.31
EV/EBITDA 10.98
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CARM may justify a higher PE ratio.
PEG (NY)1.22
PEG (5Y)0.34
EPS Next 2Y5.14%
EPS Next 3Y4.49%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.34%, CARM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.11, CARM pays a better dividend. On top of this CARM pays more dividend than 80.49% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, CARM pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.34%

5.2 History

The dividend of CARM decreases each year by -4.29%.
Dividend Growth(5Y)-4.29%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

54.49% of the earnings are spent on dividend by CARM. This is a bit on the high side, but may be sustainable.
DP54.49%
EPS Next 2Y5.14%
EPS Next 3Y4.49%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (3/21/2025, 7:00:00 PM)

17.2

-0.14 (-0.81%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)04-17 2025-04-17
Inst Owners31.45%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap2.44B
Analysts81.33
Price Target20.75 (20.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.34%
Yearly Dividend1.21
Dividend Growth(5Y)-4.29%
DP54.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.27%
PT rev (3m)7.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.66%
Revenue NY rev (3m)1.86%
Valuation
Industry RankSector Rank
PE 7.78
Fwd PE 9.6
P/S 4.8
P/FCF 8.31
P/OCF 8.22
P/B 0.71
P/tB 0.71
EV/EBITDA 10.98
EPS(TTM)2.21
EY12.85%
EPS(NY)1.79
Fwd EY10.42%
FCF(TTM)2.07
FCFY12.04%
OCF(TTM)2.09
OCFY12.17%
SpS3.58
BVpS24.11
TBVpS24.1
PEG (NY)1.22
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 4.65%
ROE 9.19%
ROCE 7.04%
ROIC 4.52%
ROICexc 4.63%
ROICexgc 4.63%
OM 89.71%
PM (TTM) 61.91%
GM 73.12%
FCFM 57.84%
ROA(3y)2.69%
ROA(5y)1.6%
ROE(3y)5.18%
ROE(5y)3.03%
ROIC(3y)3.52%
ROIC(5y)3.08%
ROICexc(3y)3.79%
ROICexc(5y)3.29%
ROICexgc(3y)3.79%
ROICexgc(5y)3.29%
ROCE(3y)5.48%
ROCE(5y)4.8%
ROICexcg growth 3Y20.72%
ROICexcg growth 5Y9%
ROICexc growth 3Y20.74%
ROICexc growth 5Y9.01%
OM growth 3Y17.79%
OM growth 5Y7.19%
PM growth 3Y11.44%
PM growth 5Y20.21%
GM growth 3Y2.7%
GM growth 5Y-0.75%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 9.4
Debt/EBITDA 5.84
Cap/Depr 77.82%
Cap/Sales 0.6%
Interest Coverage 3.75
Cash Conversion 64.59%
Profit Quality 93.43%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 0.97
F-Score5
WACC5.09%
ROIC/WACC0.89
Cap/Depr(3y)129.75%
Cap/Depr(5y)102.72%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.14%
Profit Quality(3y)3321.64%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15358.74%
EPS 3Y18.46%
EPS 5Y22.86%
EPS Q2Q%815.55%
EPS Next Y6.37%
EPS Next 2Y5.14%
EPS Next 3Y4.49%
EPS Next 5YN/A
Revenue 1Y (TTM)9.72%
Revenue growth 3Y5.68%
Revenue growth 5Y2.93%
Sales Q2Q%19.15%
Revenue Next Year11.76%
Revenue Next 2Y4.63%
Revenue Next 3Y3.14%
Revenue Next 5YN/A
EBIT growth 1Y57.69%
EBIT growth 3Y24.48%
EBIT growth 5Y10.33%
EBIT Next Year5.6%
EBIT Next 3Y5.28%
EBIT Next 5Y4.34%
FCF growth 1Y8.47%
FCF growth 3Y4.44%
FCF growth 5Y0.82%
OCF growth 1Y7.33%
OCF growth 3Y4.74%
OCF growth 5Y1.02%